The Clinton Herald, Clinton, Iowa

Food & Health

October 2, 2013

First pre-surgical breast cancer drug

WASHINGTON — A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease.

The Food and Drug Administration approved Perjeta for women with a form of early-stage breast cancer who face a high risk of having their cancer spread to other parts of the body.

Surgery to remove tumors is usually the first step in treating most forms of cancer. Perjeta is the first drug to be approved as a pre-surgical step.

Doctors hope that using cancer drugs earlier could help shrink tumors, making them easier to remove. In some cases, that could allow women to keep their breasts, rather than having a full mastectomy. Doctors also say that treating the disease at its earliest stages could prevent tumors from returning later, though studies have not yet established that benefit.

“By making effective therapies available to high-risk patients in the earliest disease setting, we may delay or prevent cancer recurrences,” said FDA’s Dr. Richard Pazdur, who directs the agency’s office of cancer products.

Cancer specialists already use several chemotherapy drugs as initial treatments for cancer, but they are not formally approved for the use. The FDA originally approved Perjeta to treat breast cancer that has spread to other parts of the body after surgery.

The FDA granted the drug accelerated approval for its new use based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations. Accelerated approval is reserved for drugs that show groundbreaking results for treating life-threatening diseases in early studies.

As a condition of approval, Roche’s Genentech unit must conduct a larger follow-up study showing the drug’s long-term benefits for patients. Generally that means showing that patients lived longer or had a higher quality of life due to taking the drug. Genentech, based in South San Francisco, Calif., has already enrolled about 4,800 patients in the follow-up study, with results expected in 2016.

Text Only
Food & Health
  • American sunscreens need an upgrade

    The last time a new sunscreen ingredient came on the U.S. market, the Y2K bug was threatening to destroy our way of life. Intel had just introduced the Pentium III processor, featuring an amazing 500 MHz of computing power.

    April 24, 2014

  • A 'wearable robot' helps her walk again

    Science is about facts, numbers, laws and formulas. To be really good at it, you need to spend a lot of time in school. But science is also about something more: dreaming big and helping people.

    April 23, 2014

  • Center warns people of fertilizer dangers IOWA CITY (AP) -- Doctors at the University of Iowa Burn Treatment Center are worried by a spike in injuries from anhydrous ammonia, a chemical used to fertilize corn crops. The center usually sees one or two cases of burns in a year, but this spring

    April 23, 2014

  • New Americans turn to goats to address food demand COLCHESTER, Vt. -- A bunch of kids in a minivan are solving twin challenges in northern Vermont: refugees struggling to find the food of their homelands and farmers looking to offload unwanted livestock. The half dozen kids -- that is, baby goats --

    April 22, 2014

  • FDA Electronic Cigarettes-3 [Duplicate] Industry awaits federal regulation RICHMOND, Va. -- Smokers are increasingly turning to battery-powered electronic cigarettes to get their nicotine fix. They're about to find out what federal regulators have to say about the popular devices. The Food and Drug Administration will propo

    April 22, 2014 1 Photo

  • Do your genes make you procrastinate?

    Procrastinators, in my experience, like nothing better than explaining away their procrastination: General busyness, fear of failure, and simple laziness are just a handful of the excuses and theories often tossed around. Now researchers from the University of Colorado Boulder have added another option to the list: genetics.

    April 21, 2014

  • Kids get codeine in ER despite risks, guidelines

    Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a study suggests.

    Use of the drug in that setting is hardly rampant — just 3 percent of kids' ER visits resulted in a codeine prescription in 2010, the 10-year study found. But with more than 25 million ER visits by children each year, the authors say far too many kids are getting the drug when better options are available.

    April 21, 2014

  • USDA orders farms to report pig virus infections MILWAUKEE -- Farms stricken with a deadly pig virus must report outbreaks as part of a new program to help monitor and possibly control the spread of the disease, the federal government announced Friday. Porcine epidemic diarrhea has killed millions

    April 19, 2014

  • The case for separate beds

    The other night I slept on a twin bed in the guest room of the house I share with my husband and our two kids.
    It was the best night's sleep I've had in years.

    April 17, 2014

  • Raw oysters spike U.S. rise in bacterial infections, CDC reports

    Raw oysters, so good with hot sauce, increasingly can carry something even more unsettling to the stomach: A bacteria linked to vomiting, diarrhea and pain.

    April 17, 2014

Parade
Magazine

Click HERE to read all your Parade favorites including Hollywood Wire, Celebrity interviews and photo galleries, Food recipes and cooking tips, Games and lots more.